ZX-7101A

DRUG7 trials

Sponsors

Nanjing Zenshine Pharmaceuticals

Conditions

Drug InteractionFood EffectInfluenza, HumanPharmacokineticsRespiratory Viral InfectionSafety IssuesTolerance

Phase 1

Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers

CompletedNCT05217732

Nanjing Zenshine PharmaceuticalsFood Effect, Pharmacokinetics, Safety Issues +1

Start: 2021-12-01End: 2022-12-19Updated: 2023-07-21

A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy Adult Subjects in China

CompletedNCT05949385

Nanjing Zenshine PharmaceuticalsPharmacokinetics

Start: 2023-07-02End: 2024-01-11Updated: 2024-11-05

A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects

CompletedNCT05955027

Nanjing Zenshine PharmaceuticalsInfluenza, Human

Start: 2023-07-08End: 2023-12-15Updated: 2024-11-04

A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects

CompletedNCT06057103

Nanjing Zenshine PharmaceuticalsDrug Interaction

Start: 2023-08-28End: 2024-04-26Updated: 2024-11-04

Phase 2

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

CompletedNCT05702489

Nanjing Zenshine PharmaceuticalsInfluenza, Human

Start: 2022-07-17End: 2023-10-13Updated: 2024-11-05

Phase 3

Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza

CompletedNCT06099873

Nanjing Zenshine PharmaceuticalsRespiratory Viral Infection

Start: 2023-11-30End: 2025-02-13Updated: 2025-02-19

Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza

TerminatedNCT06669351

Nanjing Zenshine PharmaceuticalsRespiratory Viral Infection

Start: 2024-10-31End: 2025-07-15Updated: 2025-08-13